Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research from University of Helsinki outlined
May 29th, 2008
" Finding new immunohistochemical markers that are specific to hereditary breast cancer could help us to select candidates for BRCA1/BRCA2 mutation testing and to understand the biological pathways of tumour development. Using breast cancer tumour microarrays, immunohistochemical expression of cytokeratin (CK)- 5/6, CK-14 and CK- 17 was evaluated in breast tumours from BRCA1 families (n = 46), BRCA2 families (n = 40), non- BRCA1/ BRCA2 families (n = 358) and familial breast cancer patients with one first- degree relative affected by breast or ovarian cancer (n = 270), as well as from patients with sporadic breast cancer (n = 364)," scientists in Helsinki, Finland report....
Source: Women's Health Weekly (2008-05-29)
|
